Meeting in the Millyard 2026
June 9, 2025
Save the date for Meeting in the Millyard 2026, ARMI’s signature convening of leaders in regenerative medicine, innovation, policy, and workforce development.
Save the date for Meeting in the Millyard 2026, ARMI’s signature convening of leaders in regenerative medicine, innovation, policy, and workforce development.
ARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
ARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ.
ARMI joins Wicked STEM 2025 with hands-on exhibits and a keynote, introducing students to careers in biomanufacturing and the future of regenerative medicine.
ARMI | BioFabUSA at NDIA 2025: Biofabrication for National Security
BioFabUSA showcases regenerative medicine innovations to support warfighter readiness, recovery, and military healthcare.
Hosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
Learn more about bolstering translational research to address women’s health needs.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
